Liu Dongfang 4
4 · Nuvation Bio Inc. · Filed Nov 24, 2025
Insider Transaction Report
Form 4
Liu Dongfang
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Class A Common Stock
2025-11-20$1.87/sh+20,000$37,400→ 38,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−20,000→ 450,000 totalExercise: $1.87Exp: 2034-02-27→ Class A Common Stock (20,000 underlying) - Sale
Class A Common Stock
2025-11-20$7.00/sh−20,000$140,074→ 18,000 total
Footnotes (2)
- [F1]Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.00 to $7.005. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]Option vested as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.